Suggestions
Journal Information
Vol. 19. Issue 4. (In progress)
(October - December 2026)
Cite
Cite
Share
Download PDF
More article options
Visits
341
Vol. 19. Issue 4. (In progress)
(October - December 2026)
Original Article
Full text access

Effect of active vision therapy on task-based saccadic and smooth pursuit performance in children with anisometropic amblyopia

Visits
341
Manisha Koirala, Sanjeev Bhattarai, Jyoti Baba Shrestha, Radhika Adhikari, Sanyam Pradhan, Sarmila Acharya, Gauri Shankar Shrestha
Corresponding author
gauri.shrestha@iom.tu.edu.np

Corresponding author at: Department of Ophthalmology, Maharajgunj Medical Campus, Institute of Medicine, Nepal.
Department of Ophthalmology, Maharajgunj Medical Campus, Institute of Medicine, Nepal
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (4)
fig0001
fig0002
fig0003
fig0004
Tables (4)
Table 1. Baseline characteristics of study participants in the AVT–occlusion and occlusion-only groups.
Tables
Table 2. Within-group longitudinal changes in visual and oculomotor task performance following AVT–occlusion and occlusion-only therapy in children with anisometropia.
Tables
Table 3. Between-group comparison of 3-month change scores and time × therapy interaction.
Tables
Table 4. Partial correlation between improvement in oculomotor task performance and visual outcomes (baseline to three months).
Tables
Additional material (1)
Abstract
Purpose

To evaluate the association between Active Vision Therapy (AVT) combined with occlusion and occlusion-only therapy in task-based saccadic and pursuit visuomotor performance and visual outcomes in children with anisometropic amblyopia.

Methods

Forty children (median age=9years, IQR=7–11) with persistent anisometropic amblyopia after six weeks of spectacle adaptation were alternately assigned to AVT–occlusion (n = 23) or occlusion-only (n = 17). BCVA, stereopsis, contrast sensitivity, and task-based saccadic and smooth pursuit performance were measured at baseline, three weeks, six weeks, and three months. AVT included structured monocular and binocular exercises using Vision Training System 4 and Cheiroscope, while occlusion involved daily patching of the fellow eye. Repeated-measures ANOVA and Friedman tests evaluated changes over time, partial Spearman correlations adjusted for group examined associations between oculomotor and visual improvements.

Results

Both groups improved in BCVA, and task-based saccadic and smooth pursuit performance (p < 0.05) in the AVT–occlusion group. Significant time × therapy interactions were found for BCVA, task-based saccadic and smooth pursuit performance, and contrast sensitivity (p ≤ 0.03). At three months, AVT–occlusion outperformed occlusion-only in BCVA (−0.13 logMAR, p = 0.01), task-based saccadic response time (−0.78 ms equivalent, P < 0.001) and task-based smooth pursuit performance (4.68%, p = 0.03), and contrast sensitivity (0.06 log-units, p = 0.005). Greater gain in task-based saccadic (ρ=-0.43, p = 0.006) and smooth pursuit (ρ=-0.53, p = 0.001) performance correlated with BCVA improvement; faster saccadic response performance (ρ=0.35, p = 0.026) correlated with better stereopsis.

Conclusions

AVT with occlusion was associated with greater improvements in functional visuomotor task performance and visual outcomes in children with anisometropic amblyopia, supporting its role as a function-oriented adjunct to conventional therapy.

Keywords:
Anisometropic amblyopia
Active vision therapy
Saccadic eye movements
Smooth pursuit
Visual acuity
Oculomotor rehabilitation
Abbreviations:
AVT
Occ
VA
BCVA
D
M
F
RE
LE
logMAR
ETDRS
CS
SD
IQR
ms
sec
Full Text
Introduction

Amblyopia is a neurodevelopmental disorder characterized by reduced best-corrected visual acuity (BCVA) in one or both eyes without any detectable structural abnormality, affecting approximately 4.3% of children worldwide.1,2 It remains a leading cause of preventable unilateral visual impairment that can persist into adulthood. Based on etiology, amblyopia is classified as strabismic, refractive, or deprivation.3 Refractive amblyopia arises from uncorrected refractive error during the critical period of visual development, leading to chronic suppression and altered cortical processing.

Beyond reduced acuity, amblyopia is associated with widespread functional deficits. Children with amblyopia often exhibit impairments in contrast sensitivity, stereopsis, accommodative response, visuomotor integration, and oculomotor control.4–6 Abnormalities in saccadic and pursuit eye movements, including increased latency, reduced accuracy, fixation instability, and altered pursuit gain, are thought to be associated with alterations in cortical and subcortical networks that support visuomotor behaviour.4,7 These deficits negatively impact reading efficiency, visual tracking, spatial attention, and fine motor tasks, contributing to functional disability.8

Conventional amblyopia treatment focuses on refractive correction followed by occlusion therapy, both of which primarily target monocular acuity improvement.9 Although clinically effective, occlusion alone seldom normalizes binocularity or oculomotor function, and recurrence rates remain substantial.10,11 Active Vision Therapy (AVT) has gained attention as an adjunctive, neuroplasticity-based intervention that employs structured visual activities aimed at improving functional visual and visuomotor performance, including fixation stability, saccadic and pursuit accuracy, binocular coordination, and higher-order visual processing.12,13 Digital platforms such as the Vision Training System 4 (VTS4) incorporate interactive, multisensory tasks designed to stimulate cortical adaptation and improve functional performance.14 VTS4-based measurements represent task-based visuomotor performance metrics rather than direct eye-tracking–based physiological recordings.

Various therapeutic approaches have been explored to address amblyopia beyond conventional occlusion therapy, each targeting different aspects of visual dysfunction. Traditional occlusion primarily improves monocular visual acuity but has limited effects on binocular integration and oculomotor control. In contrast, dichoptic therapies and video game–based interventions aim to reduce interocular suppression and enhance binocular function through balanced stimulation of both eyes, with several studies demonstrating improvements in stereopsis and contrast sensitivity.15–17 Perceptual learning approaches, which involve repetitive practice of visual tasks, have also shown potential in refining visual processing and, to some extent, visuomotor performance.18

However, these approaches differ substantially in their mechanisms and therapeutic targets, and their effects on oculomotor function remain inconsistently characterized. While abnormalities in saccadic latency, accuracy, and smooth pursuit gain are well documented in anisometropic amblyopia,4,7 most intervention studies have focused primarily on sensory outcomes such as visual acuity and stereopsis, with relatively limited attention to objective changes in eye movement behaviour. Moreover, existing studies on binocular or dichoptic therapies have rarely incorporated structured oculomotor training components or standardized task-based assessments of saccadic and pursuit performance.

Active Vision Therapy (AVT) represents a multimodal approach that integrates monocular, binocular, vergence, and oculomotor training within a structured framework. Despite its increasing clinical use, there is a paucity of evidence specifically examining whether AVT can modify visuomotor task performance, particularly task-based saccadic response time, accuracy, and smooth pursuit performance, in children with anisometropic amblyopia, and whether such changes are associated with improvements in visual outcomes.

Therefore, the present study aims to address this gap by evaluating the effect of Active Vision Therapy combined with occlusion, compared with occlusion alone, on task-based saccadic and smooth pursuit performance in children with anisometropic amblyopia. In addition, the study examines the association between changes in oculomotor parameters and improvements in visual outcomes, to better understand the functional role of oculomotor rehabilitation in amblyopia management.

Materials and methodsStudy design and participants

A hospital-based, quasi-experimental design was conducted among 40 children (median age = 9.0 years, IQR = 7 – 11) undergoing treatment for anisometropic amblyopia at the Orthoptic Unit of B.P. Koirala Lions Centre for Ophthalmic Studies (BPKLCOS), Institute of Medicine, Kathmandu, Nepal.

A sample size estimation was performed using G*Power (version 3.1.9.7) based on a repeated-measures ANOVA (between–within interaction), with two groups and four measurement time points. The predefined primary outcome for sample size calculation was the change in task-based saccadic and pursuit performance, selected as the principal functional visuomotor endpoints of the study. However, as no prior studies have reported effect sizes for these specific task-based oculomotor outcomes in children with anisometropic amblyopia undergoing active vision therapy, a proxy effect size was derived from related visual function outcomes. Accordingly, effect size estimation was informed by a previous active vision therapy study reporting significant between-group differences in stereopsis,5 which showed a large effect size of f = 0.72 for ANOVA. To avoid overestimation based on this effect size, a conservative effect size (f = 0.25) was assumed, with α = 0.05 and power = 0.80, yielding an estimated required sample size of 24 participants. The final sample of 40 participants in the present study therefore exceeded this requirement.

Amblyopia was defined as an interocular acuity difference of 0.2 logMAR or greater between the amblyopic eye and fellow eye, and the fellow eye acuity equal to or better than 0.2 logMAR with no measurable strabismus, nystagmus or structural ocular pathology.19 Anisometropic amblyopia was defined as anisometropia >1.5 Diopter (D) (spherical or spherical equivalent).

All eligible participants had previously undergone cycloplegic refraction using cyclopentolate HCL 1% w/v (Auropent, Aurolab, Madhurai, India) administered three-times at 10-minute intervals, with refraction performed one hour after the first eye drop instillation. Each participant had been provided with an appropriate best-spectacle correction and completed six-week period of full-time spectacle adaptation prior to baseline assessment. This six-week period was selected as a pragmatic clinical threshold to identify children demonstrating limited early response to refractive correction while avoiding unnecessary delay in initiating adjunctive therapy within a hospital-based setting. This decision was further informed by clinical practice patterns and evidence suggesting that the majority of optical treatment effects occur within the initial weeks of correction, although continued improvement may occur beyond this period. Participants were included only if visual acuity remained stable or showed no clinically meaningful improvement after six weeks, thereby operationally defining “persistent amblyopia” for the purpose of initiating adjunctive therapy.

Children who provided verbal assent along with written parental consent were included. Exclusion criteria comprised ocular conditions known to affect eye movements (strabismus and nystagmus), astigmatism ≥ 2.50 D, retinal pathologies, and any history of ocular trauma or surgery, significant cognitive or neurological impairment, anticipated difficulty adhering to treatment schedules, or prior exposure to vision therapy. Additionally, children who discontinued the assigned AVT or occlusion therapy during the study period were also excluded.

Following confirmation of eligibility and completion of informed consent procedures, participants were allocated using an alternating sequence to either AVT–Occlusion group or the Occlusion-only group. This approach was adopted for feasibility within the clinical setting but does not constitute true randomization. The study was conducted in accordance with the principles of the Declaration of Helsinki for research involving human subjects and received ethical approval from the Institutional Review Committee of the Institute of Medicine [Protocol No 2826–11E2–081/82].

Clinical assessment

Visual Acuity (VA): Presenting VA and BCVA were assessed monocularly at four meters using a LogMAR chart (ETDRS format) chart under standardized room illumination. Participants were seated comfortably and aligned with the centre of the chart. Following verbal instructions, one eye was occluded without applying pressure, and the participant was asked to read optotypes from the top line downward until no further letters could be correctly identified. VA was scored using a letter-by-letter LogMAR method, and the lowest line read accurately was recorded. The procedure was repeated for the fellow eye and subsequently following spectacle correction.

Stereopsis: Stereopsis was assessed using the Titmus Fly Test (Stereo Optical Co., Chicago, IL, USA) at 40 cm testing distance under proper room illumination. Participants wore polarized glasses over their habitual spectacle correction and were instructed to identify the three-dimensional fly and graded circle patterns. The smallest disparity level correctly perceived (in ′) was recorded as the stereo-acuity threshold.

Contrast Sensitivity (CS): CS was measured using the Pelli-Robson CS chart (Precision Vision Inc, Woodstock, IL, USA) at a distance of one m under uniform lighting conditions. Participants wore their best spectacle correction, and testing was performed monocularly by occluding the fellow eye. Letters of decreasing contrast were read aloud until the participant was unable to correctly identify at least two letters in a triplet. The final correctly identified contrast level was recorded, and the procedure was repeated for the fellow eye.

Assessment of task-based saccadic and pursuit performance

Task-based saccadic and smooth pursuit performance was assessed as functional measures of visuomotor task performance using the VTS4 Projector Computer Orthoptics System (HTS Inc. version 1.8.3, Gold Canyon, AZ 85,118, USA). The VTS 4 is a computer-based vision therapy and orthoptic platform used in optometric and ophthalmologic clinical settings to assess and train binocular vision and oculomotor skills (HTS Vision. VTS4 System Manual. HTS Inc.; 2022. Available from: https://htsvision.com). The system presents dichoptic stimuli using synchronized liquid crystal glasses or augmented reality displays to engage each eye independently and jointly, enabling a range of interactive exercises (e.g., smooth vergence, jump ductions, pursuits, saccades) and automated measurements (e.g., fusional ranges, phorias, fixation disparities, stereopsis, visual memory) that support the evaluation and management of binocular vision anomalies such as vergence disorders, suppression, and accommodative dysfunctions.14

Participants were seated comfortably at a viewing distance of three meters from the display screen and wore activated 3D liquid crystal glasses throughout testing. No practice or familiarization trials were provided prior to data acquisition. The decision was made to maintain consistency with clinical assessment conditions. However, this may have introduced a learning effect, whereby repeated exposure to task-based paradigms contributed to performance improvements independent of physiological changes in oculomotor control.

Participants responded manually via a gamepad to indicate target location or maintain target alignment. Although these measures reflect task-based visuomotor performance, they do not provide direct physiological recordings of eye movement latency or gain. The saccadic task quantified task-based accuracy and response time based on manual button presses, while task-based smooth pursuit performance was assessed as the percentage of time the moving target remained within a reference box during tracking tasks. These metrics reflect task performance involving visuomotor coordination and response behavior, rather than direct measurements of eye movement kinematics.

Assessment of task-based saccadic eye movement performance

The saccade assessment module was selected, and participants were provided with a handheld game switch pad to register responses. Randomly positioned arrows pointing up, down, left, or right appeared on the screen. Participants were instructed to respond as quickly and accurately as possible by pressing the corresponding directional button. Each correct response resulted in a random change in arrow position and direction, maintaining continuous saccadic demand. Testing was conducted monocularly for three minutes per eye, with the fellow eye occluded during assessment and the procedure repeated for the opposite eye. The system automatically recorded mean response time (saccadic speed) and percentage of correct responses for each eye.

Assessment of task-based smooth pursuit eye movement performance

Following completion of the saccadic assessment, the pursuit module was selected. A moving dinosaur (target) and a reference box were presented dichoptically, with the eye being tested viewing the target and the fellow eye viewing the box. Participants were instructed to use a mouse to keep the moving target within the box as it traversed the screen. The assessment was conducted monocularly for three minutes per eye, with target speed standardized at three seconds per movement cycle. The system automatically quantified pursuit performance as the percentage of time the target remained inside the box (on-target) versus outside the box (off-target), providing an objective measure of smooth pursuit accuracy and control.

InterventionOcclusion therapy

Occlusion therapy was administered using an adhesive occlusion patch applied directly over the non-amblyopic (fellow) eye. The patching regimen was individualized according to the type and severity of amblyopia. For anisometropic amblyopia, the fellow eye was patched daily during waking hours. Children with mild to moderate amblyopia were instructed to patch for two hours per day, while those with severe amblyopia patched for six hours per day.5 Based on the severity of VA, amblyopia was classified as mild to moderate (best-corrected VA from 0.2 logMAR 0.6 logMAR) and severe (best-corrected VA > 0.6 logMAR).

Compliance with occlusion therapy was assessed at each follow-up visit through parental reports. Participants were considered compliant if they adhered to greater than or equal to 70% of the prescribed occlusion duration. To enhance adherence, parents were repeatedly counselled on the importance of consistent patching for visual improvement and prevention of amblyopia recurrence. In addition, weekly telephone calls were made to parents or caregivers to reinforce instructions, address practical difficulties, and provide motivation. Parents were encouraged to integrate patching into daily routines such as homework or near tasks to improve acceptability.

Active vision therapy (AVT)

AVT was delivered using VTS4 following a standardized and progressive protocol (Figs. 1and2, Supplementary Table 1). Participants were seated comfortably at a viewing distance of three meter from the display screen and wore activated 3D liquid crystal glasses throughout the therapy sessions. AVT sessions were conducted twice weekly for 12 weeks, resulting in a total of 24 supervised sessions.14

Fig. 1.

Active vision therapy using the Cheiroscope in the VTS4 Projector Computer Orthoptics System. (A) Cheiroscope with a large dot on a uniform background. (B) Cheiroscope with a large dot on a pictorial background. (C) Cheiroscope with a large dot on an alternative pictorial background. (D) Cheiroscope with a small dot on a pictorial background. (E) Large moving cursor used during Cheiroscope training (indicated by a red-pointed arrow). (F) Small moving cursor used during Cheiroscope training (indicated by a red-pointed arrow).

Fig. 2.

Active Vision Therapy delivered using the VTS4 Projector Computer Orthoptics System. (A) Road Race (vergence training): children were instructed to align a target (“GO”) appearing in depth using the response button. (B) Saccadic performance assessment: randomly positioned directional arrows appeared on the screen, and participants responded using a game switch pad (indicated by a red-pointed arrow). (C) Smooth pursuit performance assessment: a moving target (dinosaurs) and a reference box were presented dichoptically, and participants were instructed to maintain the target within the box using a mouse (indicated by a red-pointed arrow). (D) Amblyopia module: children identified and read randomly distributed letters presented on the screen.

Cheiroscope training

Cheiroscope therapy was initiated to enhance binocular coordination and visuomotor integration. The amblyopic eye viewed a moving dot while the fellow eye viewed tracing lines. Participants traced the dot along prescribed paths using a mouse. Training began with a large-dot stimulus on a uniform background for five minutes per eye, followed by large-dot tracing on a pictorial background for five minutes per eye. This sequence was repeated for the first eight sessions (Weeks 1–4). From session nine onward, the same protocol was continued using a small-dot stimulus, maintaining identical durations and background conditions (Fig. 1).

Vergence training (Road-race)

Following Cheiroscope therapy, Vergence training was conducted using the Roadrace module. Participants manipulated a rotary control knob on the gamepad to position a car beneath a green “GO” target appearing in depth and confirmed alignment using the response button. Vergence demand increased by one unit after two consecutive correct responses and decreased by two units following an incorrect response, allowing adaptive task difficulty. This module was performed binocularly for 10 min per session throughout the intervention period (Fig. 2.A).

Training on saccadic eye movement performance

Saccadic performance training was conducted using the saccade therapy module. Randomly positioned directional arrows appeared on the screen, and participants responded using a game switch pad. Each correct response triggered a change in arrow position and direction. Training was performed monocularly for five minutes per eye, with the fellow eye occluded during testing (Fig. 2B).

Training on smooth pursuit performance

Smooth pursuit performance training followed, in which a moving target and reference box were presented dichoptically. The amblyopic eye viewed the moving target, while the fellow eye viewed the box. Participants were instructed to maintain the target within the box using the mouse. Training was performed monocularly for five minutes per eye, with target speed standardized at three seconds per movement cycle (Fig. 2C).

Amblyopia module

Finally, the amblyopia training module was used, requiring participants to identify and read randomly distributed letters presented on the screen. This task was conducted for five minutes per eye (Fig. 2D).

The AVT program incorporated both monocular and binocular components and was administered in a structured, progressive manner to target oculomotor control, vergence function, and visual processing (Supplementary Table 1).

Statistical analysis

Data normality was assessed using the Shapiro–Wilk test. Continuous variables are presented as mean ± SD (standard deviation) or median (IQR, Interquartile range), and categorical variables as frequencies and percentages. Baseline characteristics were compared using independent t-tests or Mann–Whitney U tests for continuous variables and Chi-square or Fisher’s exact tests for categorical variables.

Within-group longitudinal changes across baseline, three weeks, six weeks, and three months were analyzed using repeated-measures ANOVA for normally distributed variables, with Greenhouse–Geisser correction applied when required. Non-normally distributed outcomes (stereopsis) were analyzed using the Friedman test with Bonferroni-adjusted post-hoc comparisons. Effect sizes were reported as partial eta squared (η²p). Given the non-randomized allocation, analyses were interpreted as assessing associations between intervention and outcomes rather than definitive causal effects.

Between-group longitudinal effects were examined using two-way repeated-measures ANOVA, with time as the within-subject factor and therapy group as the between-subject factor. Given the quasi-experimental design and limited sample size, multivariable adjustment for covariates (e.g., age, baseline amblyopia severity, and adherence) was not performed to avoid model overfitting and unstable parameter estimates. Baseline comparability was assessed to minimize confounding risk. However, residual confounding cannot be excluded, and between-group effects should be interpreted cautiously as associative rather than fully adjusted causal estimates. Between-group differences in three-month change scores were assessed using independent t-tests or Mann–Whitney U tests, as appropriate, with mean differences and 95% confidence intervals reported.

Partial correlations between changes in oculomotor parameters and visual outcomes adjusted for therapy group were assessed using Spearman coefficients, based on data distribution, using baseline-to–three-month change scores.

Statistical significance was set at α = 0.05. All analyses were performed using SPSS version 22.0 (IBM Corp., Armonk, NY, USA).

ResultsBaseline characteristics

Of the 40 children included in the analysis, 23 received AVT–occlusion therapy and 17 received occlusion-only treatment (Table 1). The median age did not differ significantly between groups (p = 0.26), and gender distribution was comparable (p = 0.96). Median spherical equivalent refractive error was similar in the AVT–occlusion and occlusion-only groups (+2.75 D [IQR: 1.5–4.0] vs +3.0 D [IQR: 2.4–4.4]; p = 0.45). The severity of amblyopia was also comparable between groups, with the majority of participants having mild to moderate amblyopia (87.0%vs 88.2%; p = 1.0).

Table 1.

Baseline characteristics of study participants in the AVT–occlusion and occlusion-only groups.

CharacteristicsAVT– Occlusion  Occlusion-only  P-value 
Age in years [median (IQR)]9 (7.0 – 14.0)  9.0 (6.5 – 9.5)  0.26* 
Gender [No. (%)]Male  11 (47.8)  8 (47.1)  0.96§
Female  12 (52.2)  9 (52.9) 
SE in Diopters [median (IQR)]+2.75 (1.5 – 4.0)  + 3.0 (2.4 – 4.4)  0.45* 
Severity [No. (%)]Mild to Moderate  20 (87.0)  15 (88.2)  1.0
Severe  3 (13.0)  2 (11.8) 

AVT = Active vision therapy, No = number, SE = Spherical Equivalent Refractive Error, IQR = Inter-quartile range.

Mann-Whitney U test.

§

Chi-square test

Independent sample t-test

Fisher’s exact test.

Within-group longitudinal changes in visual and oculomotor outcomes

Within-group analysis revealed significant longitudinal improvements in multiple visual and saccadic and pursuit eye movements in both treatment groups (Table 2).

Table 2.

Within-group longitudinal changes in visual and oculomotor task performance following AVT–occlusion and occlusion-only therapy in children with anisometropia.

VariablesPre-treatment(mean ± SD)Post-treatmentPost-hoc comparisonsp-value*, η2p 
3-week(mean ± SD)  6-week(mean ± SD)  3-month(mean ± SD)   
AVT–Occlusion          P1  P2  P3   
BCVA  0.42±0.19  0.35±0.13  0.27±0.10  0.12±0.07  0.005  <0.001  <0.001  <0.001, 0.72 
Stereopsis (′)§  100 (80–400)  80 (100–400)  80 (60–200)  60 (40–80)  1.0  0.003  <0.001  0.015, 0.33# 
Contrast sensitivity (log units)  1.83±0.17  1.83±0.17  1.84±0.16  1.94±0.18  0.13  0.004  0.001, 0.50 
Task-based saccadic accuracy performance (%)  87.4 ± 11.5  90.9 ± 9.4  92.5 ± 9.2  98.7 ± 2.4  0.004  0.001  <0.001  <0.001, 0.49 
Task-based Saccadic response time (ms equivalent)  2.13±0.76  1.92±0.66  1.57±0.54  0.95±0.31  <0.001  <0.001  <0.001  <0.001, 0.79 
Task-based smooth pursuit on-target performance (%)  79.9 ± 11.3  83.4 ± 10.4  87.5 ± 8.8  91.6 ± 7.3  <0.001  <0.001  <0.001  <0.001, 0.66 
Occlusion-only                 
BCVA  0.43±0.17  0.37±0.16  0.31 ± 0.14  0.25 ± 0.10  0.019  0.001  <0.001  <0.001, 0.62 
Stereopsis (′)§  100 (80–400)  80 (80–400)  60 (100 – 200)  80 (60 – 100)  1.0  0.07  0.015  0.015, 0.21# 
Contrast sensitivity (log units)  1.82±0.06  1.82±0.06  1.83±0.06  1.83±0.06  0.98  0.98  0.16, 0.12 
Task-based saccadic accuracy performance (%)  79.1 ± 13.2  84.0 ± 12.4  85.6 ± 10.7  89.9 ± 9.8  0.086  0.01  0.002  <0.001, 0.48 
Task-based Saccadic response time (ms equivalent)  2.69±0.76  2.52±0.69  2.45±0.65  2.29±0.60  0.009  0.002  0.01  0.001, 0.47 
Task-based smooth pursuit on-target performance (%)  71.3 ± 6.7  73.7 ± 6.7  75.5 ± 6.3  78.4 ± 6.2  <0.001  0.001  <0.001  <0.001, 0.69 
§

values for stereopsis was reported as median (Interquartile range, IQR)

BCVA = Best-Corrected Visual Acuity (log MAR), SD = Standard Deviation, AVT = Active vision therapy, sec =second, ms =millisecond

P1, P2, and P3 denote Bonferroni-adjusted pairwise comparisons between baseline and 3-week, 6-week, and 3-month follow-up, respectively.

p-values were calculated using Greenhouse–Geisser correction using repeated-measures ANOVA for all normally distributed variables; Friedman test for non-normally distributed variable (stereopsis).

Data on homogeneity of variance unavailable to adjust for Greenhouse–Geisser correction.

η2p = partial eta Squared (effect size).

#

Kendall’s W (effect size)

Overall Friedman test p-value < 0.001 for stereopsis in both groups.

In the AVT–occlusion group, repeated-measures analysis demonstrated significant improvements in BCVA, task-based saccadic accuracy and response time, and smooth pursuit performance as early as three weeks, with progressive gains sustained through three months (all p < 0.001; large effect sizes, η²p = 0.49–0.79). Stereopsis showed significant improvement by 6 weeks (p = 0.003) and further improvement at three months (p < 0.001), while contrast sensitivity improved only at three months (p = 0.004).

In the occlusion-only group, BCVA, task-based saccadic accuracy, saccadic response time, and smooth pursuit performance also improved significantly over time (all overall p < 0.001), though changes were generally smaller in magnitude. Stereopsis demonstrated delayed improvement, reaching statistical significance only at three months (p = 0.015), while contrast sensitivity showed no significant change across follow-up visits (p = 0.16).

Between-group longitudinal changes in visual and oculomotor task performance

Repeated-measures ANOVA showed a significant main effect of time (p < 0.001, η²p = 0.74) and a time × therapy interaction (p = 0.01, η²p = 0.23) on BCVA, indicating faster and greater improvement in the AVT–occlusion group (Table 3). Post-hoc analyses confirmed significant improvement from baseline at all follow-ups (all p < 0.001), with a steeper linear trajectory in the AVT–occlusion group (Fig. 3A). At three months, BCVA improvement was greater in AVT–occlusion versus occlusion-only (mean difference = −0.13, 95% CI −0.19 to −0.07, p = 0.010).

Table 3.

Between-group comparison of 3-month change scores and time × therapy interaction.

OutcomesAVT–Occlusion (Change in score from baseline to three months)(Mean ± SD)Occlusion-only (Change in score from baseline to three months)(Mean ± SD)Between-group mean difference (95% CI)p-valueBetween-group treatment effect
TimeTime X Therapy
p-value  Partial η²  p-value  Partial η² 
BCVA  −0.30±0.15  −0.18±0.13  −0.13 (−0.19 to −0.07)  0.01  <0.001  0.66  0.01  0.13 
Stereopsis (′)*  −40 (−230 to −15)  −20 (−120 to −20)  0 (−20 to 60)  0.8§ 
Contrast sensitivity (log units)  0.11± 0.17  0.01 ± 0.05  0.06 (0.01 to 0.10)  0.005  0.001  0.24  0.003  0.21 
Task-based saccadic accuracy performance (%)  11.3 ± 9.9  10.8 ± 10.1  0.47 (−6.1 to 7.0)  0.89  <0.001  0.56  0.57  0.05 
Task-based saccadic response time (ms equivalent)  −1.18 ± 0.49  −0.40 ± 0.46  −0.78 (0.40 – 1.17)  <0.001  <0.001  0.72  <0.001  0.51 
Task-based smooth pursuit on-target performance (%)  11.79 ± 8.24  7.11 ± 5.45  4.68% (1.82 – 7.54)  0.03  <0.001  0.78  0.03  0.10 

AVT = Active vision therapy, SD = Standard deviation, CI = confidence interval, ms = millisecond.

*values for stereopsis was reported as median (Interquartile range, IQR).

SD = standard deviation, CI = confidence interval, BCVA = best-corrected visual acuity.

§

Between-group comparisons of change scores were performed using Mann–Whitney U tests.

Between-group comparisons of change scores were performed using independent t-tests

Between-group treatment effect derived from repeated-measures ANOVA with Greenhouse–Geisser correction

* Friedman test for non-normal data).

Negative values indicate improvement for BCVA, stereopsis and saccadic response time; positive values indicate improvement for other outcomes.

Fig. 3.

Effect of intervention on Best-corrected visual acuity (BCVA), and task-based saccadic and pursuit eye movement performances. Changes in BCVA, and task-based saccadic and smooth pursuit eye movement performances from baseline to three months following intervention are shown for the AVT–occlusion and occlusion-only groups. Panels A, B, C and D illustrate BCVA, task-based saccadic accuracy, saccadic response time and smooth pursuit on-target, respectively. Data are presented as estimated marginal means at each time point, with separate lines for each treatment group to highlight between-group differences over time.

Stereopsis improved over three months in both groups, with slightly larger median gain in AVT–occlusion (−40 ′) than occlusion-only (−20 ′). However, the between-group difference was not statistically significant (p = 1.0), indicating comparable gains in stereopsis with both treatment approaches over the study period.

Contrast sensitivity increased significantly over time (p = 0.001, η²p = 0.24), with a significant Time × Therapy interaction (p = 0.003, η²p = 0.21). Post-hoc analyses revealed that contrast sensitivity improved mainly in the AVT–occlusion group at three months (mean difference = 0.06, 95% CI 0.01–0.10, p = 0.005), while occlusion-only showed no meaningful change.

Task-based saccadic accuracy improved over time in both groups (p < 0.001, η²p = 0.56) with no significant Time × Therapy interaction (p = 0.57), indicating similar improvement trajectories (Fig. 3B). Task-based saccadic response time improved significantly over time (p < 0.001, η²p = 0.72), with a significant Time × Therapy interaction (p < 0.001, η²p = 0.51), showing faster gains in AVT–occlusion (mean difference at three months = 0.78, 95% CI 0.40–1.17, p < 0.001; Fig. 3C).

Task-based smooth pursuit on-target percentage (a functional visuomotor performance measure) improved over time (p < 0.001, η²p = 0.78) with a significant Time × Therapy interaction (p = 0.03, η²p = 0.10), reflecting greater and faster improvement in the AVT–occlusion group (Fig. 3D). All post-hoc comparisons from baseline were significant (p < 0.001).

Correlation between oculomotor task performance and visual gains

Partial Spearman correlation adjusted for therapy group indicated functional associations between oculomotor task performance and visual improvements (Table 4,Fig. 4). Specifically, greater task-based saccadic accuracy was correlated with improved BCVA (ρ = −0.43, p = 0.006, Fig. 4.A), and faster task-based saccadic response time was associated with better stereopsis (ρ = 0.36, p = 0.026, Fig. 4.C). Changes in task-based smooth pursuit performance showed significant correlation only with BCVA (ρ = −0.53, p = 0.001, Fig. 4.B). These findings indicate an association between improvements in oculomotor task performance and visual outcomes, independent of therapy type.

Table 4.

Partial correlation between improvement in oculomotor task performance and visual outcomes (baseline to three months).

Oculomotor parameter (Change from baseline to three months)  Visual outcome (Change from baseline to three months)  Partial correlation (rho)  p-value 
Task-based saccadic accuracy performance (%)Best-Corrected Visual Acuity  – 0.43  0.006* 
Stereopsis  – 0.26  0.11 
Contrast sensitivity  0.25  0.13 
Task-based saccadic response time (ms)Best-Corrected Visual Acuity  0.25  0.21 
Stereopsis  0.35  0.026* 
Contrast sensitivity  0.01  0.94 
Task-based smooth Pursuit on-target performanceBest-Corrected Visual Acuity  – 0.53  0.001* 
Stereopsis  – 0.14  0.40 
Contrast sensitivity  0.09  0.61 

AVT = Active vision therapy, ms = millisecond.

Partial Spearman correlations were adjusted for therapy group (AVT-Occlusion and Occlusion-only).

Analyses were performed in SPSS using the PARTIAL CORR command. Change scores for each variable were ranked, and correlations were computed while controlling for the therapy group.

Fig. 4.

Relationship between improvement in oculomotor parameters and visual outcomes from baseline to three months. Dotted bands around the fitted lines represent the 95% confidence intervals for the mean. AVT-Occlusion = active vision therapy plus occlusion therapy Partial Spearman correlations, adjusted for therapy group, were statistically significant for: (A) task-based saccadic accuracy versus best-corrected visual acuity (rho = –0.43, p = 0.006), (B) task-based smooth pursuit on-target versus best-corrected visual acuity (rho = –0.53, p = 0.001), and (C) task-based saccadic response time versus stereopsis (rho = 0.35, p = 0.026).

Discussion

This hospital-based longitudinal study demonstrated that AVT combined with occlusion was associated with greater improvements in visual function and performance on oculomotor tasks, indicating enhanced functional visuomotor control, compared with occlusion therapy alone in children with anisometropic amblyopia. It is important to note that our measures reflect behavioural task performance rather than direct recordings of eye movement latency or gain. Importantly, these findings address a key gap in the literature by providing objective evidence that a structured, multimodal vision therapy program can improve performance on visuomotor tasks, including task-based saccadic response time, accuracy, and smooth pursuit performance, in this population.

Previous research has shown that amblyopic individuals exhibit delayed and imprecise saccades and other visuomotor dysfunctions, reflecting disrupted cortical processing and impaired binocular integration.4,20 While conventional occlusion therapy remains effective in improving best-corrected visual acuity, it primarily targets monocular sensory input and may not adequately address oculomotor deficits such as abnormal saccadic and pursuit eye movement, which are increasingly recognised as integral features of amblyopia-related visual dysfunction.1,21

In contrast to conventional approaches, emerging therapies such as dichoptic training, video game–based interventions, and perceptual learning have been developed to target binocular function and cortical plasticity. These approaches have demonstrated improvements in stereopsis and contrast sensitivity15–17, but their effects on oculomotor control remain less consistently reported. Notably, most of these interventions do not explicitly incorporate structured saccadic or pursuit training components, nor do they routinely quantify changes in eye movement behaviour using task-based metrics. The present findings therefore extend the existing literature by demonstrating that a therapy paradigm explicitly integrating task-based oculomotor training can yield measurable improvements in both task-based saccadic and smooth pursuit performance.

In the present study, both AVT–occlusion and occlusion-only groups experienced significant within-group gains in BCVA, stereopsis, contrast sensitivity, and parameters of oculomotor task performance over three months (Table 2). The AVT–occlusion group demonstrated faster and larger improvements in task-based saccadic accuracy, saccadic response time, and smooth pursuit performance, with significant time × therapy interactions (Table 3). These findings suggest that while spontaneous or occlusion-driven improvements in oculomotor task performance may occur, targeted visuomotor training accelerates and enhances these adaptations. While the AVT–occlusion group demonstrated faster and larger improvements across several outcomes, the use of an alternating (non-random) allocation procedure limits the ability to draw causal inferences from these findings. As allocation was predictable and not concealed, the possibility of selection bias cannot be excluded, even though measured baseline characteristics were comparable between groups. Accordingly, the observed between-group differences should be interpreted as associations rather than definitive evidence of treatment efficacy. These findings are hypothesis-generating and support the need for well-designed randomized controlled trials with concealed allocation to confirm the causal effects of AVT on oculomotor and visual performances.

The BCVA gains observed in the study (0.30 logMAR for AVT–occlusion vs 0.18 logMAR for occlusion-only, mean difference −0.13, 95% CI −0.19 to −0.07, p = 0.01) aligned with previous reports. Suwal et al. (2024) similarly reported gains of 0.32 ± 0.11 logMAR with AVT and 0.27 ± 0.19 logMAR with patching, with AVT showing particular benefit in severe amblyopia (p = 0.031) .5 Differences between studies likely reflect variations in baseline severity, therapy intensity, adherence, sample size, and participant characteristics.

The relatively short six-week optical adaptation period, shorter than that used in major amblyopia clinical trials, may have influenced baseline stabilization and partially confounded interpretation of between-group differences. The definition of persistent amblyopia after six weeks of optical adaptation warrants careful consideration. Previous studies, including those from the Pediatric Eye Disease Investigator Group (PEDIG), have demonstrated that visual acuity can continue to improve with refractive correction alone for up to 12–16 weeks or longer. Accordingly, it is possible that some participants in the present study may have experienced additional gains with continued optical adaptation alone.22,23 However, the decision to initiate adjunctive therapy after six weeks was guided by the absence of clinically meaningful improvement during this period and reflects a pragmatic, clinic-based approach aimed at avoiding delays in treatment escalation. Importantly, both study groups were subjected to the same adaptation duration, which helps preserve internal comparability, although it does not eliminate the possibility that longer adaptation could have attenuated between-group differences. Future studies incorporating longer optical adaptation periods are warranted to better isolate treatment effects.24

In the study, stereopsis improved in both groups (40 ′ for AVT–occlusion vs 20 ′ for occlusion-only), although the between-group difference was not significant (p = 0.80). Early studies reported minimal or inconsistent stereo gains, but recent approaches using dichoptic stimulation, perceptual learning, and virtual reality have demonstrated significant and sustained improvements.15,16 For example, Vedamurthy et al. (2015) reported dichoptic video game training improved stereoacuity by 0.27 log arcsec (46%) immediately post-training and 0.24 log arcsec (42%) at follow-up in adults with anisometropic amblyopia.17 Compared with these approaches, the stereopsis gains observed with AVT in the present study were modest, which may reflect differences in therapeutic emphasis, as AVT in this protocol prioritized task-based oculomotor and visuomotor training alongside binocular engagement rather than exclusively targeting interocular suppression. Similarly, Suwal et al. observed significant stereoacuity gains over three months with both active vision therapy (0.32 ± 0.11 logMAR) and occlusion (0.27 ± 0.19 logMAR), with greater improvement in the AVT group with severe amblyopia (p = 0.03) .5 Variations across studies likely reflect differences in age, baseline stereoacuity, amblyopia severity, therapy type, intensity, duration, adherence, and outcome measures. Compared with dichoptic or perceptual learning therapies, AVT appears comparable for BCVA and gain in oculomotor task performance, while stereopsis improvements were modest, likely reflecting ceiling effects in children with mild-to-moderate amblyopia and limited statistical power.18

Although the AVT–occlusion group demonstrated a statistically significant improvement in contrast sensitivity at three months (mean difference = 0.06 log units, p = 0.005). This change is modest and may approach the known test–retest variability of the Pelli-Robson chart, typically reported as 0.05–0.15 log units, indicating that changes smaller than this range may reflect measurement variability rather than true clinical change.25 Therefore, while the improvement suggests a positive trend, its clinical relevance should be interpreted cautiously.

Functional associations between gain in oculomotor task performance and sensory improvements further emphasize the interdependence of sensory and motor recovery.26 Improvements in task-based saccadic accuracy (ρ = −0.43, p = 0.006) and smooth pursuit (ρ = −0.53, p = 0.001) performances were significantly correlated with BCVA gains, and faster task-based saccadic response time (ρ = 0.35, p = 0.026) was associated with better stereopsis. These findings support the hypothesis that improvements in oculomotor task performance are not merely secondary effects but may contribute functionally to visual recovery, reinforcing the rationale for integrating training on visuomotor task performance into amblyopia rehabilitation. This supports the view that amblyopia is not solely a monocular acuity deficit but involves binocular and visuomotor dysfunction that benefits from multi-component rehabilitation.27 Age and gender were not included as covariates in these association analyses because baseline distributions were comparable between groups, and the study was not powered to support age- or sex-specific subgroup analyses.

The observed improvements in visuomotor task performance likely reflect enhanced functional task execution rather than direct evidence of neural changes. AVT tasks, including saccadic jumps, smooth pursuit tracking, vergence, and binocular coordination, are designed to engage visuomotor and attention-related processes. Previous studies have implicated regions such as the middle temporal visual area, parietal cortex, and frontal eye fields in motion processing and visuospatial control28–30, which are relevant to the types of tasks used in the present study. However, the current findings should be interpreted as improvements in behavioural task performance, as no direct neurophysiological or eye-tracking measurements were performed. In contrast, occlusion therapy primarily targets monocular form vision, which may partly explain the comparatively smaller improvements observed in visuomotor task performance in the occlusion-only group.1

Clinically, structured task-based saccadic, pursuit, and binocular coordination exercises can complement traditional occlusion therapy, offering a more comprehensive approach by targeting both sensory and motor components of visual function.31,32 This is particularly relevant given that many contemporary amblyopia therapies emphasize sensory recovery, whereas functional visual performance in real-world tasks depends heavily on efficient oculomotor task performance. Although the observed changes were statistically significant, further research is needed to determine the extent to which these improvements translate into real-world functional benefits such as reading efficiency, academic performance, and visuomotor coordination.

Several limitations should be considered when interpreting these results. First, the use of an alternating allocation strategy rather than true randomization represents a key methodological limitation. This quasi-experimental design introduces potential selection bias and limits internal validity, thereby weakening the strength of causal inferences. Although baseline characteristics were comparable, unmeasured confounding cannot be excluded.

Second, although sample size estimation was informed by prior stereopsis outcomes, the study was not originally powered based on a predefined primary endpoint, and therefore findings should still be interpreted with consideration of potential type II error for smaller effects. In addition, the absence of allocation concealment and masking (blinding) of outcome assessment may have introduced performance and assessor bias.

Third, an important consideration is the potential influence of practice (learning) effects. AVT participants were repeatedly exposed to the same computerized tasks during training and assessment without prior familiarization. Consequently, some improvements in task-based saccadic and smooth pursuit performance may reflect increased task familiarity, enhanced hand–eye coordination, or strategy optimization rather than purely physiological changes in oculomotor control. While the occlusion-only group followed the same assessment schedule, additional exposure during AVT sessions may have amplified these learning effects. Therefore, between-group differences should be interpreted cautiously, as they may partially reflect practice-related gains rather than solely treatment-specific effects. Finally, follow-up was limited to three months, precluding long-term outcome assessment.

Given the non-randomized allocation and modest sample size, adjusted analyses including multiple covariates (e.g., age, baseline amblyopia severity, and treatment adherence) were not performed to avoid overfitting and unstable estimates. Baseline comparability for key demographic and clinical variables was confirmed, and occlusion adherence was broadly similar across participants. Nonetheless, residual confounding related to age, baseline severity, or adherence cannot be excluded and may have influenced between-group comparisons and effect estimates. Taken together, the absence of predefined covariate adjustment, non-random allocation, and lack of task familiarization introduce potential sources of bias that may have influenced between-group estimates and should be considered when interpreting the magnitude of observed effects.

In summary, AVT combined with occlusion is associated with accelerated and improvements in task-based saccadic and smooth pursuit performance, alongside visual acuity gains, in children with anisometropic amblyopia. By directly addressing oculomotor task performance, a relatively underexplored domain in amblyopia intervention studies, these findings support a function-oriented, multimodal approach to amblyopia rehabilitation. Larger, randomized trials with long-term follow-up and functional outcome measures are warranted to confirm these findings and establish optimal AVT protocols in pediatric amblyopia.

Conclusion

Active Vision Therapy combined with occlusion was associated with greater and faster improvements in both oculomotor task performance and visual function in children with anisometropic amblyopia compared with occlusion alone. Specifically, AVT–occlusion demonstrated greater improvements in task-based saccadic accuracy, task-based saccadic response time, and task-based smooth pursuit performance, along with earlier improvements in BCVA and stereopsis. These results highlight a potential association between sensory and visuomotor functional recovery and support the use of function-oriented, binocularly based vision therapy protocols as adjuncts to conventional occlusion therapy. However, these findings should be interpreted with consideration of potential practice effects related to repeated task exposure, and studies incorporating gold-standard eye-tracking, longer optical adaptation periods, and randomised control designs are needed to confirm these preliminary findings.

Funding

None.

Declaration of competing interest

No potential conflict of interest.

Acknowledgements

We thank all B.Optom final-year students of the 2024/25 academic year for their assistance in patient communication and data collection. We are also grateful to the Prof. Dr Sagun Joshi, Executive Director and the entire administrative team for providing logistical support and facilitating the conduct of all tests and therapies free of charge.

Appendix
Supplementary materials

Icono mmc1.docx

Appendix: Supplementary materials (Supplementary Table 1)

References
[1]
J.M. Holmes, M.P. Clarke.
Amblyopia.
Lancet, 367 (2006), pp. 1343-1351
[2]
A. Mostafaie, M. Ghojazadeh, H. Hosseinifard, H. Manaflouyan, F. Farhadi, N. Taheri, et al.
A systematic review of amblyopia prevalence among the children of the world.
Rom J Ophthalmol, 64 (2020), pp. 342-355
[3]
R.B. Zagui.
Amblyopia: types, diagnosis, treatment, and new perspectives.
Am Acad Ophthalmol, 25 (2019), pp. 2-4
[4]
E. Niechwiej-Szwedo, H.C. Goltz, M. Chandrakumar, Z.A. Hirji, A.M. Wong.
Effects of anisometropic amblyopia on visuomotor behavior, I: saccadic eye movements.
Invest Ophthalmol Vis Sci, 51 (2010), pp. 6348
[5]
R. Suwal, M.K. Dev, B. Khatri, D. Khadka, A. Shrestha, S. Sharma, et al.
Impact of active vision therapy compared to conventional patching therapy on visual acuity and stereoacuity in children with amblyopia.
J Optom, 17 (2024),
[6]
I.A.M. Suliman, A.L.I. MSA.
The effect of amblyopia on contrast sensitivity, color vision, and stereoacuity.
Al-Basar Int J Ophthalmol, 4 (2017), pp. 54
[7]
Y. Fan, H. Zuo, P. Chu, Q. Wu, L. Li, Y. Wang, et al.
Analyses of eye movement parameters in children with anisometropic amblyopia.
BMC Ophthalmol, 24 (2024), pp. 278
[8]
A.L. Webber.
The functional impact of amblyopia.
Clin Exp Optom, 101 (2018), pp. 443-450
[9]
S. Kaur, S. Sharda, H. Aggarwal, S. Dadeya.
Comprehensive review of amblyopia: types and management.
Indian J Ophthalmol, 71 (2023), pp. 2677-2686
[10]
R. Saxena, S. Puranik, D. Singh, V. Menon, P. Sharma, S. Phuljhele.
Factors predicting recurrence in successfully treated cases of anisometropic amblyopia.
Indian J Ophthalmol, 61 (2013), pp. 630
[11]
J.M. Holmes, M. Melia, Y.S. Bradfield, O.A. Cruz, B. Forbes, P.E.D.I Group.
Factors associated with recurrence of amblyopia on cessation of patching.
Ophthalmology, 114 (2007), pp. 1427-1432
[12]
D.P. Munoz, S. Everling.
Look away: the anti-saccade task and the voluntary control of eye movement.
Nat Rev Neurosci, 5 (2004), pp. 218-228
[13]
R.J. Krauzlis.
Recasting the smooth pursuit eye movement system.
J Neurophysiol, 91 (2004), pp. 591-603
[14]
F. Zhao, L. Xi, B. Deng, J. Zeng, W. Li.
Visual training system 4: a promising adjuvant therapy for ocular accommodative function and visual acuity improvement in refractive amblyopia patients.
Am J Transl Res, 16 (2024), pp. 7859-7867
[15]
J.A. Portela-Camino, S. Martin-Gonzalez, J. Ruiz-Alcocer, I. Illarramendi-Mendicute, R.A. Garrido-Mercado.
Random dot computer video game improves stereopsis.
Optom Vis Sci, 95 (2018), pp. 523-535
[16]
K.R. Kelly, R.M. Jost, Y.Z. Wang, L. Dao, C.L. Beauchamp, J.N. Leffler, et al.
Improved binocular outcomes following binocular treatment for childhood amblyopia.
Invest Ophthalmol Vis Sci, 59 (2018), pp. 1221
[17]
I. Vedamurthy, M. Nahum, S.J. Huang, F. Zheng, J. Bayliss, D. Bavelier, et al.
A dichoptic custom-made action video game as a treatment for adult amblyopia.
Vis Res, 114 (2015), pp. 173-187
[18]
C.E. Stewart, M.J. Moseley, P. Georgiou, A.R. Fielder.
Occlusion dose monitoring in amblyopia therapy: status, insights, and future directions.
[19]
M. Bossi, V.K. Tailor, E.J. Anderson, P.J. Bex, J.A. Greenwood, A. Dahlmann-Noor, et al.
Binocular therapy for childhood amblyopia improves vision without breaking interocular suppression.
Invest Ophthalmol Vis Sci, 58 (2017), pp. 3031
[20]
D.M. Levi.
Linking assumptions in amblyopia.
Vis Neurosci, 30 (2013), pp. 277-287
[21]
E.E. Birch.
Amblyopia and binocular vision.
Prog Retin Eye Res, 33 (2013), pp. 67-84
[22]
A.M. Chen, S.A. Cotter.
The amblyopia treatment studies: implications for clinical practice.
Adv Ophthalmol Optom, 1 (2016), pp. 287-305
[23]
S. Sen, P. Singh, R. Saxena.
Management of amblyopia in pediatric patients: current insights.
[24]
C. Stewart, M. Moseley, A. Fielder, D. Stephens.
Refractive adaptation in amblyopia: quantification of effect and implications for practice.
Br J Ophthalmol, 88 (2004), pp. 1552-1556
[25]
D.B. Elliott, K. Sanderson, A. Conkey.
The reliability of the Pelli-Robson contrast sensitivity chart.
Ophthalmic Physiol Opt, 10 (1990), pp. 21-24
[26]
D.M. Levi, D.C. Knill, D. Bavelier.
Stereopsis and amblyopia: a mini-review.
[27]
Y. Zhou, H. Bian, X. Yu, W. Wen, C. Zhao.
Quantitative assessment of eye movements using a binocular paradigm: comparison among amblyopic, recovered amblyopic and normal children.
BMC Ophthalmol, 22 (2022), pp. 365
[28]
W.T. Newsome, E.B. Pare.
A selective impairment of motion perception following lesions of the middle temporal visual area (MT).
[29]
O. Braddick, J. Atkinson, J. Wattam-Bell.
Normal and anomalous development of visual motion processing: motion coherence and 'dorsal-stream vulnerability.
Neuropsychologia, 41 (2003), pp. 1769-1784
[30]
J.C. Culham, N.G. Kanwisher.
Neuroimaging of cognitive functions in human parietal cortex.
Curr Opin Neurobiol, 11 (2001), pp. 157-163
[31]
D.M. Levi.
Rethinking amblyopia 2020.
Vis Res, 176 (2020), pp. 118-129
[32]
R.F. Hess, B. Thompson.
Amblyopia and the binocular approach to its therapy.
Copyright © 2026. The Author(s)
Download PDF
Journal of Optometry
Article options
Tools
Supplemental materials